Science updates
25 Mar 2024EAHAD 2024 catch-up: access the latest findings on gene therapy in haemophilia
The European Association for Haemophilia and Allied Disorders (EAHAD) Congress 2024 took place last month, where CSL Behring sponsored the symposium ‘Unlocking the next step in gene therapy for haemophilia: The end of the beginning?’ and released new long-term longevity data for AMT-060 and etranacogene dezaparvovec (AMT-061).
For those who could not attend, or would like to watch the symposium again, the symposium recording is now available to watch on-demand here.